This spring, the pandemic abruptly brought global apprehension and uncertainty. Medical practitioners desperately endeavored to navigate increased safety protocols while continuing to provide optimal care for their patients. Consequently, forecasters began to observe that reliance on medical technology solutions that can support safer exam scenarios would dramatically increase. During this challenging transition, Mitch Reinholt, OD discovered that one of his favorite diagnostic tools became more valuable than ever.
In April, Dr. Reinholt found himself with a bare-bones staff, providing some telemedical visits, but ultimately bringing patients in and doing most of the exams on his own. He found that his California helped to expedite exams and reduce patient exposure as well as time in the office. California, like all optomap UWF retinal imaging devices, capture over 200 degrees of the retina in 1/2 second. It provides a dynamic image that can be enlarged and manipulated to see into the retinal layers and with autofluorescence to assess function, as well. Reinholt explained that he could capture the image quickly, then withdraw to review it and evaluate if further diagnostics were required.
Reinholt acquired his California device in 2019 primarily for clinical value and the ability to get unmatched retinal information, but also …